COVID-19: Frequently asked clinical questions
Should I continue to vaccinate my pediatric population during peak COVID-19?
EU panel review supports decision to pull Picato from market
The review found “a higher occurrence of skin cancers, especially squamous cell carcinoma, in areas of skin treated with Picato than in areas...
Financial incentives affect the adoption of biosimilars
Adoption of infliximab biosimilars proceeded more slowly at an academic medical center than at a neighboring VAMC, where financial incentives to...
COVID-19 PPE-related skin effects described in survey of Chinese doctors, nurses
Almost 75% of doctors and nurses in and around Wuhan, China, reported skin problems during a single week in early February.
Most e-consults not followed by specialist visit
The results reflect experts’ positive experiences with e-consults.
A decade of telemedicine policy has advanced in just 2 weeks
User-friendly technology and the relaxed telehealth restrictions have made it fairly simple for patients and physicians to connect.
iPLEDGE allows at-home pregnancy tests during pandemic
FDA approves ixekizumab for pediatric plaque psoriasis
A phase 3 study showed a safety profile similar in both pediatric and adult patients, albeit with greater rates of conjunctivitis, influenza, and...
New topicals coming for pediatric atopic dermatitis
LAHAINA, HAWAII – Novel noncorticosteroid topicals will fill an unmet need in atopic dermatitis.
Does screening by primary care providers effectively detect melanoma and other skin cancers?
EVIDENCE-BASED ANSWER: Possibly. No trials have directly assessed detection of melanoma and other skin cancers by primary care providers.